Tumor Microenvironment-Responsive Drug Delivery Based on Polymeric Micelles for Precision Cancer Therapy: Strategies

Zhu Jin1, Majdi Al Amili1, Shengrong Guo1

  • 1Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.

Biomedicines
|February 24, 2024
PubMed

Insights

Tumor microenvironment-responsive polymeric micelles enhance cancer precision therapy by targeting tumors. These advanced drug delivery systems show promise for improved efficacy in gene therapy and immunotherapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Cancer drug therapy faces limitations in efficiency and toxicity.
  • Polymeric micelles offer a strategy for tumor-targeted drug delivery.
  • Environmentally responsive materials are key for targeted delivery systems.

Purpose of the Study:

  • To review strategies for constructing tumor microenvironment (TME)-responsive polymeric micelles.
  • To highlight their role in enhancing precision cancer therapy.
  • To discuss their potential in gene therapy and immunotherapy.

Main Methods:

  • Review of existing literature on TME-responsive polymeric micelles.
  • Analysis of TME characteristics (low pH, ROS, hypoxia, enzymes) for stimuli-responsive design.
  • Exploration of micelle strategies for enhanced antitumor efficacy.

Main Results:

  • TME-responsive polymeric micelles demonstrate significant improvements in precision cancer therapy.
  • These micelles effectively target tumors by responding to unique TME stimuli.
  • The review outlines promising strategies for their development and application.

Conclusions:

  • TME-responsive polymeric micelles are a robust approach for targeted cancer drug delivery.
  • They offer enhanced antitumor efficacy and hold potential for future clinical applications.
  • Their application in gene therapy and immunotherapy represents a promising frontier.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K